BRD4-IN-41

Overview

BRD4-IN-41 is a BRD4 inhibitor with an IC 50 of 34 nM. BRD4-IN-41 also inhibits JAK2 , FLT3 , RET , ROS1 , NTRK3 , PDGFRb , and FGFR1 kinases with IC 50 values ranging from 0.9 nM to 43 nM. BRD4-IN-41 inhibits acetyl-lysine binding site of BRD4, downregulates c-MYC , reduces phosphorylated STAT3 levels, induces G1 cell cycle arrest and apoptosis , thereby inhibiting cancer cells growth. BRD4-IN-41 can be used for the research of cancer , such as multiple myeloma and acute myeloid leukemia.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Multiple Myeloma | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > FLT3 | Products > Signaling Pathways > RET | Products > Signaling Pathways > ROS Kinase | Products > Signaling Pathways > PDGFR | Products > Signaling Pathways > FGFR | Products > Signaling Pathways > c-Myc | Products > Signaling Pathways > STAT | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > PARP | Products > Signaling Pathways > Epigenetic Reader Domain | Products > Signaling Pathways > JAK

Product Information

• Catalog No.: HY-115541
• CAS No.: 1877286-69-5
• Molecular Formula: C26H34FN7O2S
• Molecular Weight: 527.66
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source